IVUS-Guided vs. Angiography-Guided Drug-Coated Balloon Angioplasty in the Treatment of Femoropopliteal Lesions

Angiography has traditionally been the primary imaging technique for endovascular therapy guidance in patients with peripheral artery disease. However, as it only provides two-dimensional images of lumen, it does not allow complete visualization of vascular structures. This can hinder appropriate selection of device size, balloon or stent, as well as the accurate assessment of procedural outcomes.

Intravascular ultrasound (IVUS) provides detailed information on vessel dimension and plaque characteristics. Its use has been shown to improve clinical outcomes in the treatment of complex coronary lesions. In recent years, IVUS has been increasingly used in peripheral artery disease; however, supporting clinical evidence vs standard angiography in peripheral artery interventions remains limited.

This prospective, multicenter, randomized study aimed to evaluate the outcomes of IVUS-guided vs angiography-guided treatment of femoropopliteal lesions with different levels of lesion complexity.

The primary endpoint was target lesion primary patency, defined as absence of clinically driven target lesion revascularization (CD-TLR) or restenosis at 12 months. The secondary endpoint included CD-TLR as well as clinical and hemodynamic improvement parameters.

A total of 237 patients undergoing drug-coated balloon angioplasty for femoropopliteal lesions were included in the IVUS-DCB study; 158 had complex lesions (TASC II type C/D) and 79 had non-complex lesions (TASC II type A/B).

Read also: QFR vs. FFR: Is Coronary Revascularization Deferral Safe? Results from a FAVOR III Sub-Analysis.

In complex lesions, IVUS use was associated with significantly higher primary patency (82.1% vs. 60.3%; HR: 0.34; 95% CI: 0.16-0.70; p = 0.002), lower incidence of CD-TLR (90.0% vs. 76.9%; HR: 0.31; 95% CI: 0.13-0.75; p = 0.01), and sustained clinical and hemodynamic improvement vs angiography guided angioplasty.

As regards non-complex lesions, no significant differences were observed in primary patency (87.5% vs. 88.2%; HR: 1.84; 95% CI: 0.39-8.60; p = 0.44) or incidence of secondary evaluation criteria between IVUS and angiography-guided balloon angioplasty.

Conclusion

 IVUS-guided drug coated balloon angioplasty was associated with higher primary patency rate and clinical improvement vs. the angiography-guided in the treatment of complex femoropopliteal lesions. In contrast, non-complex lesions showed no significant differences between these methods. 

Original Title: Intravascular Ultrasound-Guided vs Angiography-Guided Drug-Coated Balloon Angioplasty in Patients With Complex Femoropopliteal Artery Disease.

Reference: Seung-Jun Lee, MD et al JACC Cardiovasc Interv. 2025;18:558–569.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

 

Dr. Andrés Rodríguez
Dr. Andrés Rodríguez
Member of the Editorial Board of solaci.org

Más artículos de este Autor

New Carotid PCI All-in-One System

Carotid stenting is equivalent to carotid endarterectomy in terms of major adverse events (death, AMI, and stroke). However, it entails higher risk of minor...

PERFORMANCE II Trial: Safety and Efficacy of the New NeuroGuard Carotid Stent System

The percutaneous treatment of carotid artery disease through stenting (CAS) for the prevention of cerebrovascular disease has proven to be an effective alternative compared...

Trends in the Treatment of Critical Lower Limb Ischemia

Approximately 25% of patients with critical lower limb ischemia (CLLI) face amputation within the first year after diagnosis (according to statistics from the United...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Artículos relacionados

Jornadas SOLACIspot_img

Artículos recientes

March 26 – SOLACI Webinar: Evidence and Controversies in Renal Denervation in 2025

The Latin American Society of Interventional Cardiology invites you to a new virtual event supported by Medtronic. On this occasion, we will hold a 60-minute...

QFR vs. FFR: Is Coronary Revascularization Deferral Safe? Results from a FAVOR III Sub-Analysis

In cases of intermediate coronary lesions, functional assessment is recommended to aid the decision-making process regarding revascularization. There are several tools currently used to...

FRANCE TAVI Registry: Coronary Adverse Events After TAVI

Between 30% and 70% of patients undergoing transcatheter aortic valve implantation (TAVI) have coronary artery disease (CAD). However, the prognostic impact of CAD in...